Kimberly Smith, APN

NPI: 1053402339
Total Payments
$13,176
2024 Payments
$3,505
Companies
31
Transactions
730
Medicare Patients
1,026
Medicare Billing
$97,249

Payment Breakdown by Category

Food & Beverage$12,656 (96.1%)
Education$320.11 (2.4%)
Gifts$200.00 (1.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $12,656 725 96.1%
Education $320.11 4 2.4%
Gift $200.00 1 1.5%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $4,354 222 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $2,067 162 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $1,620 97 $0 (2024)
Janssen Biotech, Inc. $1,220 55 $0 (2024)
Gilead Sciences, Inc. $423.24 20 $0 (2024)
PFIZER INC. $394.17 23 $0 (2024)
QOL Medical, LLC $392.87 18 $0 (2024)
NESTLE HEALTHCARE NUTRITION INC. $390.55 24 $0 (2023)
Merck Sharp & Dohme LLC $293.11 13 $0 (2024)
Regeneron Healthcare Solutions, Inc. $237.16 13 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,505 196 ABBVIE INC. ($1,163)
2023 $3,496 198 ABBVIE INC. ($1,218)
2022 $3,467 179 ABBVIE INC. ($1,113)
2021 $2,708 157 AbbVie Inc. ($860.34)

All Payment Transactions

730 individual payment records from CMS Open Payments — Page 1 of 30

Date Company Product Nature Form Amount Type
12/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $8.37 General
Category: Gastroenterology
12/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $7.87 General
Category: Gastroenterology
12/19/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $18.74 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
12/18/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $20.04 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.65 General
Category: Gastroenterology
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $8.46 General
Category: Gastroenterology
12/13/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $16.12 General
Category: Immunology
12/10/2024 Janssen Scientific Affairs, LLC TREMFYA (Drug) Food and Beverage In-kind items and services $37.69 General
Category: Immunology
12/09/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $37.45 General
Category: IMMUNOLOGY
12/09/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.21 General
Category: IMMUNOLOGY
12/05/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $28.42 General
Category: Immunology
12/05/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $8.19 General
Category: Gastroenterology
12/04/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $21.73 General
Category: IMMUNOLOGY
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.77 General
Category: Gastroenterology
12/04/2024 PFIZER INC. VELSIPITY (Drug) Food and Beverage In-kind items and services $3.93 General
Category: INFLAMMATION;PAIN
12/03/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $4.06 General
Category: IMMUNOLOGY
12/02/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $29.34 General
Category: INTERNAL MEDICINE
12/02/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $6.44 General
Category: IMMUNOLOGY
11/26/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $19.98 General
Category: GASTROENTEROLOGY
11/26/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $7.78 General
Category: GASTROENTEROLOGY
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.47 General
Category: Gastroenterology
11/18/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $14.09 General
Category: IMMUNOLOGY
11/18/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $13.43 General
Category: GI
11/13/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.88 General
Category: IMMUNOLOGY
11/13/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $10.19 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 271 438 $114,369 $32,006
2022 5 371 476 $104,702 $31,177
2021 4 384 497 $103,086 $34,065
Total Patients
1,026
Total Services
1,411
Medicare Billing
$97,249
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 223 387 $100,233 $28,749 28.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 24 24 $9,384 $2,161 23.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 24 27 $4,752 $1,096 23.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 189 263 $68,117 $19,367 28.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 131 154 $27,104 $8,205 30.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 11 13 $4,511 $1,493 33.1%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 16 20 $2,500 $1,068 42.7%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 24 26 $2,470 $1,044 42.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 155 211 $54,649 $17,595 32.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 198 253 $44,528 $14,600 32.8%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 19 21 $2,625 $1,434 54.6%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 12 12 $1,284 $435.96 34.0%

About Kimberly Smith, APN

Kimberly Smith, APN is a Acute Care healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053402339.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimberly Smith, APN has received a total of $13,176 in payments from pharmaceutical and medical device companies, with $3,505 received in 2024. These payments were reported across 730 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($12,656).

As a Medicare-enrolled provider, Smith has provided services to 1,026 Medicare beneficiaries, totaling 1,411 services with total Medicare billing of $97,249. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Acute Care
  • Location Knoxville, TN
  • Active Since 09/28/2006
  • Last Updated 11/11/2022
  • Taxonomy Code 363LA2100X
  • Entity Type Individual
  • NPI Number 1053402339

Products in Payments

  • XIFAXAN (Drug) $1,852
  • ENTYVIO (Biological) $1,259
  • RINVOQ (Biological) $1,193
  • STELARA (Biological) $864.70
  • LINZESS (Drug) $835.75
  • SKYRIZI (Biological) $759.06
  • MAVYRET (Drug) $580.89
  • HUMIRA (Biological) $537.50
  • ZENPEP (Drug) $493.65
  • DUPIXENT (Biological) $376.60
  • CREON (Drug) $314.68
  • DIFICID (Drug) $293.11
  • SUCRAID (Drug) $266.04
  • TREMFYA (Drug) $234.42
  • TRULANCE (Drug) $215.10
  • RELTONE 200 MG (Drug) $214.30
  • IBSRELA (Drug) $207.77
  • VELSIPITY (Drug) $199.94
  • XELJANZ (Drug) $194.23
  • MOTEGRITY (Drug) $190.59

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Acute Care Doctors in Knoxville